U.S. FDA Approves Wynzora Cream for Plaque PsoriasisApprovals, FDA, FDA/Regulatory, Plaque Psoriasis, Skin Creams, TopicalsThe U.S. Food and Drug Administration approved MC2 Therapeutics’ Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. Read more July 22, 2020/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2020-07-22 04:00:572020-07-24 17:33:24U.S. FDA Approves Wynzora Cream for Plaque Psoriasis
